"Consistent with the existing pricing in the agreement, all...

"Consistent with the existing pricing in the agreement, all spodumene concentrate volumes will be sold based on the prevailing market price."

Assuming moving forward that China is less able to manipulate that market price then this is good. They do demand around 70% at present and so increasing our supply to them is good news. On a personal note, I am aligned with those holders that would prefer to see PLS less reliant on China and to supply more broadly into the rest-of-the-World market. We have a lot of resource and moving ahead to P1000 that broader supply opportunity will eventuate.

So, IMO, I reckon this is good and hopefully so shall the market.

GLTAH